These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17056080)

  • 1. Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine.
    Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Nagelkerke N
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):235-40. PubMed ID: 17056080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine.
    Petroianu GA; Hasan MY; Nurulain SM; Shafiullah M; Sheen R; Nagelkerke N
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):312-6. PubMed ID: 17040217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon.
    Petroianu GA; Nurulain SM; Arafat K; Rajan S; Hasan MY
    Arch Toxicol; 2006 Nov; 80(11):777-84. PubMed ID: 16598495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiapride pre-treatment in acute exposure to paraoxon: comparison of effects of administration at different points-in-time in rats.
    Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Shafiullah M; Sheen R
    Mol Cell Biochem; 2006 Apr; 285(1-2):79-86. PubMed ID: 16479322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
    Petroianu GA; Hasan MY; Arafat K; Nurulain SM; Schmitt A
    J Appl Toxicol; 2005; 25(6):562-7. PubMed ID: 16193528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective drugs in acute large-dose exposure to organophosphates: a comparison of metoclopramide and tiapride with pralidoxime in rats.
    Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Saleh A; Schmitt A
    Anesth Analg; 2005 Feb; 100(2):382-386. PubMed ID: 15673862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon.
    Petroianu GA; Nurulain SM; Shafiullah M; Hasan MY; Kuča K; Lorke DE
    J Appl Toxicol; 2013 Sep; 33(9):894-900. PubMed ID: 22611016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intrathecal pralidoxime administration upon survival of rats exposed to the organophosphate paraoxon.
    Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Nagelkerke N; Petroianu GA
    Neurotoxicology; 2008 Jul; 29(4):663-70. PubMed ID: 18457881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats.
    Shaikh J; Karanth S; Chakraborty D; Pruett S; Pope CN
    Arch Toxicol; 2003 Oct; 77(10):576-83. PubMed ID: 14574445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon.
    Petroianu GA; Nurulain SM; Nagelkerke N; Al-Sultan MA; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(3):262-8. PubMed ID: 16583462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.
    Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA
    J Appl Toxicol; 2011 Aug; 31(6):515-23. PubMed ID: 20981864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
    Eckert S; Eyer P; Mückter H; Worek F
    Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxon has only a minimal effect on pralidoxime brain concentration in rats.
    Petroianu GA; Lorke DE; Hasan MY; Adem A; Sheen R; Nurulain SM; Kalasz H
    J Appl Toxicol; 2007; 27(4):350-7. PubMed ID: 17265425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactive effects of paraoxon and pyridostigmine on blood-brain barrier integrity and cholinergic toxicity.
    Song X; Pope C; Murthy R; Shaikh J; Lal B; Bressler JP
    Toxicol Sci; 2004 Apr; 78(2):241-7. PubMed ID: 14976354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective agents in acute high-dose organophosphate exposure: comparison of ranitidine with pralidoxime in rats.
    Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sha Ullah M; Naseer O
    J Appl Toxicol; 2005; 25(1):68-73. PubMed ID: 15669039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of a protective effect of the oxime 2-PAM toward paraoxon-poisoned honey bees: acetylcholinesterase reactivation not at fault.
    Polyzou A; Froment MT; Masson P; Belzunces LP
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):184-92. PubMed ID: 9772214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of cholinesterase inhibition and clinical signs and the postmortem findings in mice after intraperitoneal administration of anatoxin-a(s), paraoxon or pyridostigmine.
    Cook WO; Dahlem AM; Harlin KS; Beasley VR; Hooser SB; Haschek WM; Carmicheal WW
    Vet Hum Toxicol; 1991 Feb; 33(1):1-4. PubMed ID: 2017858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combined, multiple stressors on pyridostigmine-induced acute toxicity in rats.
    Baireddy P; Mirajkar N; Nallapaneni A; Singleton N; Pope CN
    Arch Toxicol; 2007 Apr; 81(4):283-9. PubMed ID: 16944100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon.
    Petroianu GA; Nurulain SM; Nagelkerke N; Shafiullah M; Kassa J; Kuca K
    J Appl Toxicol; 2007; 27(5):453-7. PubMed ID: 17304644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.